Rotavirus serotype G9 Is associated with more-severe disease in Latin America
xmlui.dri2xhtml.METS-1.0.item-date
2006xmlui.dri2xhtml.METS-1.0.item-files-viewOpen
xmlui.mirage2.itemSummaryView.MetaData
xmlui.ArtifactBrowser.ItemViewer.show_fullxmlui.dri2xhtml.METS-1.0.item-uri
http://patua.iec.gov.br/handle/iec/1074xmlui.dri2xhtml.METS-1.0.item-abstract
The association between rotavirus serotypes and severity is
not well established. Analysis of a clinical trial conducted in
Latin America points at more-severe disease associated with
serotype G9. Thus, demonstration of efficacy against G9 will
be an important asset of any rotavirus vaccine to be introduced
into a Latin American country or any country where
G9 has been shown to be prevalent.
xmlui.dri2xhtml.METS-1.0.item-citation
LINHARES, Alexandre da Costa et al. Rotavirus serotype G9 Is associated with more-severe disease in Latin America. Clinical Infectious Diseases, v. 43, n. 3, p. 312-314, Aug. 2006xmlui.dri2xhtml.METS-1.0.item-decsPrimary
Rotavirus / classificaçãoInfecções por Rotavirus / epidemiologia
Gastroenterite
Vacinas contra Rotavirus / uso terapêutico
América Latina